<DOC>
	<DOCNO>NCT02345148</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetics , safety , tolerability intranasally administer esketamine elderly participant ( great equal [ &gt; = ] 75 year age ) young healthy adult participant ( 18 55 year age , inclusive ) .</brief_summary>
	<brief_title>Pharmacokinetic , Safety , Tolerability Study Intranasally Administered Esketamine Elderly Healthy Younger Adult Participants</brief_title>
	<detailed_description>This single-center , 2-cohort , single-dose , open-label study . The duration study approximately 42 day per participant . The study consist 3 part : Screening ( , 28 day study commences Day 1 ) open-label Treatment ( Day 1 ) Follow-up ( Day 13 ) . Esketamine administer intranasal route ( delivery medication nasal mucosa ) Day 1 . Participants ' safety monitor throughout study .</detailed_description>
	<criteria>For Cohort 1 , man woman , &gt; = 75 year age either healthy present stable , wellcontrolled , chronic condition frequently occur elderly , : hyperlipidemia ; control hypertension ; impaired fasting glucose , impair glucose tolerance type 2 diabetes mellitus control diet , and/or metformin monotherapy , dipeptidyl peptidase4 ( DPP4 ) inhibitor monotherapy combination metformin DPP4 inhibitor , glycated hemoglobin ( HbA1c ) level less 8 percent ; degenerative joint disorder osteoporosis ; kidney function decline appropriate age . Inclusion participant chronic , wellcontrolled stable condition Cohort 1 review agree Investigator Sponsor For Cohort 2 , man woman , 18 55 year age , inclusive For woman childbearing potential Cohort 2 , must negative serum betahuman chorionic gonadotropin ( hCG ) pregnancy test screening ; negative urine pregnancy test Day 1 If man , must agree use adequate contraception method deem appropriate investigator donate sperm study 3 month receive study drug Body mass index ( BMI ) ( weight [ kg ] /height^2 [ ] ^2 ) 18 32 kg/m^2 ( inclusive ) , body weight less 50 kg Diagnosed current previous psychiatric disorder include limited psychotic , bipolar , major depressive , anxiety disorder Clinically significant medical illness Severe renal impairment Clinically significant abnormal value hematology , clinical chemistry , urinalysis screen admission study center ( Day 1 ) deem appropriate investigator History drug alcohol abuse disorder within past 1 year , reason believe participant history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Esketamine</keyword>
	<keyword>JNJ-54135419</keyword>
</DOC>